Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Patients who continued treatment with arGLP-1 sustained their excess weight loss over time, with positive outcomes observed even up to 34 years of continuous therapy
Theratechnologies had a narrower commercial proposition, and when the European regulators pushed back, the economics of a second application apparently did not justify the spend
Prior to initiation, train patients and their caregiver(s) on proper injection technique for the prescribed ZEPBOUND presentation [see Instructions for Use]
Potential risks like gastrointestinal issues, pancreatitis, and gallbladder disease create a debate about whether weight loss benefits outweigh these risks, especially for those without severe obesity (Kushner et al., 2020)
US$ 21.48
US$ 28.87
US$ 27.46
US$ 24.16
US$ 25.41
US$ 26.24
US$ 20.85
US$ 29.54
